skyrizi
Generic: risankizumab-rzaa
Labeler: abbvie inc.Drug Facts
Product Profile
Brand Name
skyrizi
Generic Name
risankizumab-rzaa
Labeler
abbvie inc.
Dosage Form
KIT
Routes
Manufacturer
Identifiers & Regulatory
Product NDC
0074-1070
Product ID
0074-1070_247cc009-6d45-4bff-a04d-8e166830d677
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761105
Listing Expiration
2026-12-31
Marketing Start
2022-06-16
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00741070
Hyphenated Format
0074-1070
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
skyrizi (source: ndc)
Generic Name
risankizumab-rzaa (source: ndc)
Application Number
BLA761105 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/ml
- 90 mg/ml
- 180 mg/1.2 ml
- 360 mg/2.4 ml
- 600 mg/10 ml
- 60 mg/ml
- 1 ml
- 2.25 ml
Packaging
- 1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)
- 1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)
Packages (2)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "247cc009-6d45-4bff-a04d-8e166830d677", "openfda": {"nui": ["N0000192799", "N0000192798"], "unii": ["90ZX3Q3FR7"], "rxcui": ["797544", "2166136", "2166137", "2166142", "2166143", "2540692", "2540695", "2540698", "2540699", "2604618", "2604622", "2604625", "2604628", "2613758", "2613759", "2632994", "2632997", "2632999", "2633000", "2633001", "2633002", "2723331", "2723332"], "spl_set_id": ["7148c8eb-b39e-e20a-6494-a6df82392858"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)", "package_ndc": "0074-1070-01", "marketing_start_date": "20220616"}, {"sample": true, "description": "1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)", "package_ndc": "0074-1070-02", "marketing_start_date": "20220616"}], "brand_name": "Skyrizi", "product_id": "0074-1070_247cc009-6d45-4bff-a04d-8e166830d677", "dosage_form": "KIT", "product_ndc": "0074-1070", "generic_name": "Risankizumab-rzaa", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Skyrizi", "application_number": "BLA761105", "marketing_category": "BLA", "marketing_start_date": "20220616", "listing_expiration_date": "20261231"}